Bio-Rad Laboratories, Inc. (BIO)

NYSE · Healthcare · Medical Devices
$358.90-2.34%As of 2026-11-22 · USD
Last session low $353.31Last session high $369.44
52-week low $236.7352-week high $396.23
Market cap
$9.65B
Sector
Healthcare
P/E (TTM)
9.5x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)44.2In the neutral range (30 to 70)
MACD (12, 26, 9)-1.53Below its signal line (0.28); histogram -1.81
Bollinger %B (20, 2)9%Inside the bands (355.69 to 392.51)
SMA 20374.10Price is 4.1% below
SMA 50371.68Price is 3.4% below
SMA 200318.62Price is 12.6% above
ATR (20)3.49% of priceAverage true range per day
52-week position77%In the upper part of the 236.73 to 396.23 range

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.

Insider filings, 90 daysNo purchases and 3 sales (about $1.2M).
Latest fiscal yearEnded 2025-12-31: revenue of $2.58B and an operating margin of 8.5%.

More in Medical Devices